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Currently, two types of cannula are avail-
able for Medtronic insulin pump ther-
apy: the vertical Quick-set cannula
(Medtronic plc, Dublin, Ireland) and the
30-degree angle Silhouette cannula
(Medtronic plc). However, it has not been
established which cannula should be used
in speciﬁc patients. Here, we present two
Japanese patients with type 1 diabetes
who experienced unexpected episodes of
hyperglycemia caused by bending of the
vertical cannula during insulin pump
therapy.
Case 1: An 84-year-old Japanese
woman (body mass index 18.7 kg/m2)
who had fulminant type 1 diabetes
caused by drug-induced hypersensitivity
syndrome was admitted to Kanazawa
University Hospital, Kanazawa, Ishikawa,
Japan, because of repeated hyper- and
hypoglycemic episodes. Her serum and
urinary C-peptide were undetectable. We
started a continuous subcutaneous insulin
infusion (CSII) for better glycemic con-
trol. Initially, she used a 9-mm long
Quick-set cannula with the infusion set.
However, she experienced several epi-
sodes of unexpected hyperglycemia
caused by bending of the cannula tip
and agglutination, even after switching to
a 6-mm long Quick-set cannula
(Figure 1). Therefore, she switched to a
13-mm long Silhouette cannula inserted
at a 30° angle. Subsequently, she did not
experience the hyperglycemic episodes
caused by obstruction of the cannula.
Case 2: A 57-year-old Japanese man
(body mass index 21.3 kg/m2) who had
had type 1 diabetes for 7 years was
admitted to our hospital for control of
brittle diabetes. His blood glucose had
increased recently, and he had experi-
enced some hypoglycemic episodes. He
started CSII, using a 9-mm long Quick-
set cannula. He experienced some
unexpected hyperglycemic episodes, with-
out the insulin pump triggering an alarm,
caused by cannula bending, which disap-
peared after switching to the Silhouette
cannula.
The two patients experienced a total
of eight episodes of hyperglycemia. Of
these, we recognized a bent cannula in
six episodes (one with intracannula
agglutination), and a normal cannula
appearance in two episodes. Insertion
failure or extended indwelling of the can-
nula alone do not explain the cannula
problem, because four of the eight
hyperglycemic episodes occurred 24–
72 h after cannula insertion, unlike pre-
vious observations that most catheter
problems start on day 31. We speculate
that the vertical cannula tip reached the
abdominal wall and bent during use
because both of our patients were thin
(skinfold thickness 8 mm in case 1 and
10 mm in case 2). Although the 6-mm
long cannula was shorter than the
skinfold thickness in case 1, there is a
difference between the real skinfold
thickness on insertion and the thickness
on computed tomography. The cannula
bends only on reaching abdominal mus-
cle. Elderly people ﬁnd it difﬁcult to
insert vertical cannulas, and they might
not have inserted the cannulas ade-
quately. In addition, a warning should be
issued regarding the absence of a pump
alarm, which occurred in one of the
eight episodes.
We conclude that a bent vertical can-
nula tip should be considered to be a
cause of unexpected hyperglycemic epi-
sodes during CSII therapy, especially in
relatively slender people with diabetes. A
prospective randomized controlled study
comparing the outcomes of 9 mm versus
6 mm and vertical versus horizontal
cannulas in type 1 diabetic patients with
different body mass indexes, body fat
percentages and skinfold thicknesses is
necessary to prove our hypothesis.
Furthermore, the alarm system of the
CSII device should be improved, so that
it detects early cannula obstruction to
prevent unexpected hyperglycemic epi-
sodes.
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Figure 1 | A bent cannula tip and agglutination (arrow) in a 6-mm long Quick-set cannula.
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